Manufacturer record

J.P Industries: regulatory record

Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

2 batches manufactured by J.P Industries (Himachal Pradesh) were declared Not of Standard Quality between July 2024 and February 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Records by type

2 records linked to J.P Industries in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
2Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Jul 2024 to Feb 2026

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

2
NSQ batches since 2024
2
Products affected
Assay
Most common failure
Feb 2026
Latest alert

Flagged batches per year

2024 · 12026 · 1

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Metformin & Sitagliptin Tablets BP TMSG-017Mfg 2025-07 · Exp 2027-06 Sample fails the test Assay of Sitagliptin and Dissolution of Metformin Hydrochloride and Sitagliptin as per BP, as specified in the in the laboratory protocol.Assay DTL ThiruvananthapuramState lab Feb 2026
Carbamazepin e Extended-Release Tablets IP 200 mg TCRN-004Mfg 2023-10 · Exp 2025-09 DissolutionDissolution CDL KolkataCDSCO lab Jul 2024

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.